News Scan for Nov 17, 2014

Global polio developments
;
Celery-linked E coli outbreak

Polio emergency extended as vaccine-derived polio confirmed in 2 nations

The World Health Organization's (WHO's) emergency polio advisory committee met for the third time Nov 2 through Nov 7, advising that global conditions still meet the definition of a public health emergency of international concern (PHEIC), according to a Nov 14 WHO statement.

The committee noted that international spread has continued since its last meeting on Jul 31, with at least three new exportations from Pakistan into neighboring Afghanistan. No other confirmed spread has occurred since March 2014, the panel added.

The risk of new international spread from Pakistan has increased since its last meeting, based on an escalation in case numbers and no improvement in factors that help drive transmission, according to the WHO statement. However, the risk of new spread from nine other countries appears to have decreased, with only two reporting new cases since the end of July: Somalia (one case) and Afghanistan (seven).

The group said it is still concerned that implementation of its temporary recommendations is still incomplete and suggested that Pakistan take further steps, such as restricting international departures of any resident lacking proper polio vaccination documentation. Committee members urged that the PHEIC be extended another 3 months.
Nov 14 WHO statement on polio committee

In another development, the WHO on Nov 14 reported separate unrelated circulating vaccine-derived poliovirus (cVDPV) events in South Sudan and Madagascar.

The South Sudan cases involve two cVDPV type 2 cases isolated from two patients with acute flaccid paralysis (AFP) in people from an internally-displaced persons camp in Unity state, an area where as many as 33% of children are under-immunized against polio. Paralysis onsets were Sep 9 and Sep 12.

In response to the cases, immunization campaigns were held Nov 4, with further efforts scheduled from three states where civil unrest is a problem. The goals of the campaigns are to quickly stop cVDPV2 in the camps while boosting immunity to wild polivovirus type 1.

In Madagascar, cVDPV type 1 (cVDPV1) was isolated from one patient who had AFP onset on Sep 29 and three healthy contacts. Supplemental immunization campaigns are slated for December and January for the country, where as many as 25% of children are thought to be under-immunized against polio. The nation had a cVDPV2 outbreak in 2001, 2002 and 2005, and a VDPV was isolated during a research study in healthy children in 2011.
Nov 14 WHO statement on poliovirus in South Sudan and Madagascar

 

Minnesota E coli outbreak tied to California celery

An outbreak of Escherichia coli O157:H7 in northern Minnesota has been tied to celery grown in California, according to a Nov 13 report in The Californian.

The Minnesota Department of Health (MDH) confirmed that 57 members of the Fond du Lac Band of Lake Superior Chippewa were sickened by celery served at 5 tribal events from Jul 1-17. Nine people were hospitalized, although no one developed hemolytic uremic syndrome, a dangerous kidney condition associated with E coli infections, the article said.

The tainted celery came from Martignoni Ranch in Gonzales, California. The ranch is located next to a defunct dairy operation. The California Department of Public Health did not find E coli on the ranch or farm, suggesting that the celery could have been contaminated during production, the story said.

The celery was bought from Upper Lakes Food Inc. and prepared by Jim-N-Joe's Northland Katering. Other distributors included Vancouver-based Pro*Act and Mann Packing in Salinas, California.

MDH opened its investigation when five people were treated in 1 day at a hospital in Cloquet, Minnesota. The tainted celery also sickened people in Wisconsin, Alabama, Illinois, Indiana, and Ohio.
Nov 13 Californian article

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»